Effect of angiotensin II and angiotensin(1–7) on hematopoietic recovery after intravenous chemotherapy Kathleen RodgersShiquin XiongGere S. diZerega Original Article Pages: 97 - 106
A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979) Sophie CalliesDinesh P. de AlwisLeon Aarons Original Article Pages: 107 - 118
Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells Xiao-Mei HuToshihiko HiranoKitaro Oka Original Article Pages: 119 - 126
Population pharmacokinetics of oxaliplatin Jean-Pierre DelordAmine UmlilEtienne Chatelut Original Article 04 December 2002 Pages: 127 - 131
Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-L-cysteine-cDDP by TEA and PAH in the renal proximal tubule Robert J. KolbMuhammad A. GhaziDelon W. Barfuss Original Article Pages: 132 - 138
Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats Barry J. CusackBeth MusserRichard D. Olson Original Article Pages: 139 - 146
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient Andrea ZimmermannHeinrich WaltSabine D. Klein Original Paper Pages: 147 - 154
Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens Kenji KatsumataHidenori TomiokaKohichiro Kato Original Article Pages: 155 - 160
Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells Wing-Pui TsangSophia P. Y. ChauTim-Tak Kwok Original Article 03 December 2002 Pages: 161 - 166
Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics Jan MaringHenk PiersmaElisabeth G. De Vries Original Article Pages: 167 - 173
Sonodynamic therapy with photofrin II on AH130 solid tumor N. Yumita S. Umemura Original Article Pages: 174 - 178
Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer M. Vassilomanolakis G. Koumakis A. Efremidis Clinical Trial Report Pages: 179 - 183